In December, the FDA granted Emergency Use Authorizations (EUAs) to 2 Oral antiviral drugs for treatment of mild to moderate COVID-19 in outpatients at high risk of progressing to severe disease, including hospitalization or death. The long list of conditions that qualifies infected patients for a prescription for one of these agents includes age >65 […]